Dose Response of a Tubule Occlusion Agent
Clinical trial NCT01075256 · COMPLETED
Trial details
- NCT number
- NCT01075256
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-03-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.